在治疗期间,患有严重抑郁症患者的血代谢概况的变化
Yujing Du1, Xixuan Li1, Shufang Zhang2
1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277, Jiefang Avenue, Wuhan, Hubei, 430022, China.
大型抑郁症 (MDD) 涉及代谢变化. 治疗可以使这些正常化,特别是脂质和胺代谢,提供潜在的诊断和治疗生物标志物.
科学领域:
- 生物化学 生物化学
- 代谢学 代谢学 代谢学
- 神经科学是一个神经科学.
背景情况:
- 大型抑郁症 (MDD) 带来了显著的身体和心理健康风险.
- 了解MDD的代谢变化对于有效的治疗策略至关重要.
研究的目的:
- 为了确定MDD患者和健康对照人群之间的血代谢特征差异.
- 为了研究MDD治疗期间的代谢正常化.
- 探索MDD中代谢转变的潜在机制.
主要方法:
- 来自47名参与者的血样本 (12对照组,12名MDD患者在3个阶段) 用超高性能液态染色学-质谱分析.
- 多变量统计分析和K-介质聚类确定了显著的代谢物.
- 基因和基因组的京都百科全书 (KEGG) 途径分析探索了代谢机制.
主要成果:
- 在MDD患者和对照人群之间发现了14种显著不同的代谢物.
- 9-氧八甲基氨酸,伊米达酸,血栓素B2和阿拉基酸的水平在治疗后呈现正常变化.
- 构建了一个涉及4种代谢物和8种代谢途径的代谢物通路网络.
结论:
- 患MDD的发病和治疗涉及代谢途径的转变,主要是脂质和胺代谢.
- 已识别的代谢物显示出MDD诊断和治疗疗效评估的潜力.
- 这些发现为进一步研究MDD机制提供了基础.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: MDD and Dysthymia
Antidepressant Drugs: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Mania and Antimanic Drugs: Overview
Depression: Overview
